论文部分内容阅读
目的探讨胺碘酮治疗室性心动过速的临床疗效。方法选取2012—2013年新乡市中心医院收治的室性心动过速患者68例,随机分为治疗组与对照组,各34例。治疗组患者予以胺碘酮治疗,对照组患者予以利多卡因治疗。观察两组患者临床疗效、短期病死率、不良反应发生情况及左室射血分数(LVEF)。结果治疗组患者总有效率高于对照组,短期病死率、不良反应发生率低于对照组,LVEF高于对照组,差异有统计学意义(P<0.05)。结论胺碘酮治疗室性心动过速的临床疗效显著,可降低患者短期病死率及不良反应发生率。
Objective To investigate the clinical efficacy of amiodarone in the treatment of ventricular tachycardia. Methods Sixty-eight patients with ventricular tachycardia who were admitted to Xinxiang Central Hospital from 2012 to 2013 were randomly divided into treatment group and control group, with 34 cases in each group. Patients in the treatment group were treated with amiodarone, and patients in the control group were treated with lidocaine. Clinical efficacy, short-term mortality, incidence of adverse reactions and left ventricular ejection fraction (LVEF) were observed in both groups. Results The total effective rate of the treatment group was higher than that of the control group, and the incidence of short-term mortality and adverse reactions was lower than that of the control group. The LVEF was higher than that of the control group (P <0.05). Conclusion The clinical efficacy of amiodarone in the treatment of ventricular tachycardia is significant, which can reduce the short-term mortality and the incidence of adverse reactions.